Navigation Links
Living longer: Colon cancer patients gain time with radiofrequency ablation treatment
Date:3/16/2010

TAMPA, Fla. (March 16, 2010)Approximately half of Americans living with colorectal cancer will develop liver metastases at some point during the course of their disease. Radiofrequency ablation, a minimally invasive treatment that applies heat directly in the tumor causing cancer cell death with minimal associated injury to the surrounding healthy liver, contributes to prolongation of their life by nearly three years, note researchers at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa, Fla.

"Patients who have recurrent colon cancer in their liver after surgery can be treated with radiofrequency ablation, or RFA, and avoid repeated liver surgery," said Constantinos T. Sofocleous, M.D., Ph.D., FSIR, an interventional radiologist at Memorial Sloan-Kettering Cancer Center in New York, N.Y. "RFA kills target cancer tissue with heat, while sparing the healthy tissue. This is particularly important for patients who develop new colon cancer in the liver after prior surgery. In general, these patients have a smaller amount of liver tissue; another surgery is usually not possible or very difficult and associated with higher risk," added Sofocleous, an associate professor of radiology at Weill Cornell Medical College, New York, N.Y. "This research shows how interventional radiologists can treat patients who have failed a prior surgical treatment. In addition it demonstrates how the combination of all available treatment modalities and the cooperation of medical specialists can improve the outcomes and may prolong patients' lives," he explained.

Colon cancer is the second leading cause of cancer-related death in the United States, with almost 150,000 new patients diagnosed each year, said Sofocleous. Approximately half of these patients will develop liver metastases at some point during the course of their disease; the majority of the patients are not candidates for surgery. "In those who undergo surgery, recurrence is a
'/>"/>

Contact: Maryann Verrillo
mverrillo@SIRweb.org
703-460-5572
Society of Interventional Radiology
Source:Eurekalert

Page: 1 2 3

Related biology technology :

1. Touch Bionics acquires LIVINGSKIN
2. UCB Scholarship Program Awards $300,000 to Students Living with Crohns Disease
3. diaDexus, Inc. and Living Heart Foundation Offer the PLAC(R) Test to Detect Hidden Risk for Heart Attack and Stroke in Retired NFL Players
4. Living Proof, Inc.: The Launch of the Next Beauty Revolution
5. Using living cells as nanotechnology factories
6. Imaging in Living Color with Siemens Molecular CT
7. Researchers develop new way to see single RNA molecules inside living cells
8. Genomas and Institute of Living Among Organizers of Pharmacogenetics Symposium at 2009 Annual Meeting of the American Psychiatric Association
9. Video: New Way RA(TM) Talk Show Premieres Online for People Living With Rheumatoid Arthritis (RA)
10. As Predicted: Chronic Virus Found Living in Tumors of the Prostate
11. UCBs Cimzia(R) (certolizumab pegol), Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Topricin Pain Relief and Healing ... listed among nationally recommended over-the-counter (OTC) health products ... "U.S. News" Health in collaboration with "Pharmacy Times." ... 1 Pharmacists Recommended designation” in the “Topical Analgesics” ... and is the only homeopathic formula to earn ...
(Date:5/17/2013)... available in German . ... the naked eye, you can see which branch a bird ... of branches through the telephoto lens for high-magnification images requires ... are looking to study proteins, the active biomolecules of cells. ... for Molecular Systems Biology, and her colleagues have now come ...
(Date:5/17/2013)... , May 17, 2013 ... by the most innovative thought leaders of the ... & Manufacturing East conference and expo, from June ...      (Photo: http://photos.prnewswire.com/prnh/20130517/613829 ) , ... designed to deliver industry professionals practical presentations and ...
(Date:5/17/2013)... , May 17, 2013  Insero Health, Inc., a ... in epilepsy and related neurological disorders, is today reporting ... lead compound INS001 in patients with drug-resistant epilepsy.  The ... Device Trials (AED) Xll meeting by Dr. ... Chairman of Insero,s Scientific Advisory Board.  In this study, ...
Breaking Biology Technology:Pharmacists' Picks: Topical BioMedics' Topricin Listed on Top Recommended OTC Health Products 2Proteome atlas for the tuberculosis pathogen 2Proteome atlas for the tuberculosis pathogen 3MedTech Innovate Seminars: New Interactive Learning Forums at 2013 MD&M East 2Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2
... Jan. 12 Synvista Therapeutics, Inc. (NYSE Alternext ... its BENEFICIAL study, a Phase 2 double-blind, placebo-controlled, randomized trial ... measure the effect of alagebrium on exercise tolerance in patients ... completing enrollment of its BREAK ( B eginning a ...
... Ill. and SANTA ANA, Calif., Jan. 12 ,Abbott ( NYSE: ... EYE ) announced,today a definitive agreement for Abbott to acquire ... value of approximately $2.8 billion, inclusive,of estimated net debt at ... AMO,is a global leader in ophthalmic care, comprised of three ...
... Bavarian Nordic,owns several United States patents relating ... MVA-BN(R), which is the basis for its smallpox,vaccine, ... for delivering,recombinant vaccines. Bavarian Nordic has asserted three ... The claim in this case is that Oxford,BioMedica ...
Cached Biology Technology:Synvista Therapeutics Announces Progress in Phase 2 Clinical Trial Program for Alagebrium 2Synvista Therapeutics Announces Progress in Phase 2 Clinical Trial Program for Alagebrium 3Synvista Therapeutics Announces Progress in Phase 2 Clinical Trial Program for Alagebrium 4Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 2Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 3Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 4Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 5Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 6Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 7Bavarian Nordic's Case Against Oxford BioMedica 2
(Date:5/17/2013)... 2013) The AGA Research Foundation announced a new ... between the gut microbiota, one of today,s most exciting ... , The AGA Research Awards Panel selected Andrew T. ... Hospital and Harvard Medical School, Boston, as the 2013 ... will receive $25,000 of funding, commencing in July 2013, ...
(Date:5/17/2013)... May 17, 2013, Shenzhen, China---- Why Tibetan antelope ... Qinghai-Tibetan Plateau? In a collaborative research published in ... BGI, and other institutes provide evidence that some ... adaption to harsh highland environments. The data in ... specific genetic mechanisms and the biology of other ...
(Date:5/16/2013)... Bethesda, MD (May 17, 2013) Illustrating a ... the American Gastroenterological Association (AGA) Research Foundation ... Future Student Research Fellowship Award recipients. Supported by ... Kidney Diseases (NIDDK), this new award helps underrepresented ... digestive disease and nutrition research. , "By establishing ...
Breaking Biology News(10 mins):New gut microbiome research to explore red meat -- colorectal cancer pathway 2The genome sequence of Tibetan antelope sheds new light on high-altitude adaptation 2Underrepresented minority students receive fellowships in digestive disease and nutrition research 2
... found a group of mutations involved in T-cell acute ... in clinical use to treat other diseases, can eliminate ... next week in Nature Genetics and may ... The study was led by researcher Joo T. ...
... that predisposes people to acute myeloid leukemia and myelodysplasia ... the GATA2 gene. Among its several regulatory roles, ... transition of primitive blood-forming cells into white blood cells. ... families who, over generations, have had several relatives with ...
... & Dentistry at the University of Alberta have discovered that ... syndrome in some offspring that could lead to later health ... nuts and red wine, and has been shown to extend ... growing in the womb have an increased risk of developing ...
Cached Biology News:New mutations in leukemia: Researchers found mechanism that can help design future therapies 2New mutations in leukemia: Researchers found mechanism that can help design future therapies 3Gene defect that predisposes people to leukemia discovered 2Gene defect that predisposes people to leukemia discovered 3Powerful antioxidant resveratrol prevents metabolic syndrome in lab tests: U of A study 2
Direct ELISA Assay Diluent, 100 mL...
Direct ELISA Assay Diluent, 10 L...
HRP Monoclonal-Goat Diluent - 5X Concentrate, 25 mL...
... routine agarose gel electrophoresis into an automated, ... This bufferless, pre-cast system is ideal for ... digests, and more. Fully automated, robot-compatible, and ... 96 system makes your high-throughput screening assignments ...
Biology Products: